These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8710205)

  • 1. Differential sensitivity to Mg(2+)-and tubocurarine-block of frog neuromuscular junctions in summer and winter.
    Wernig A; Dorlöchter M; Palazis P
    Neurosci Lett; 1996 Mar; 207(1):41-4. PubMed ID: 8710205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine receptor bars and transmitter release in frog neuromuscular junctions.
    Dorlöchter M; Meurer S; Wernig A
    Neuroscience; 1993 Feb; 52(4):987-99. PubMed ID: 8450983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of tubocurarine on the quantum release of acetylcholine during the infrequent stimulation of a motor nerve].
    Grigor'ev VM; Danilov AF; Skliarov AI
    Fiziol Zh SSSR Im I M Sechenova; 1988 Oct; 74(10):1377-82. PubMed ID: 3265920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aldrin-transdiol on neuromuscular facilitation and depression.
    Akkermans LM; van den Bercken J; van der Zalm J
    Eur J Pharmacol; 1975 Apr; 31(2):166-75. PubMed ID: 238851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Seasonal changes in neuromuscular transmission in experiments on dissected or curarized frog muscles].
    Dobretsov MG; Bereznikovskaia EIu; Vinogradova IM
    Neirofiziologiia; 1990; 22(6):745-51. PubMed ID: 1965851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in transmitter release at frog neuromuscular junction induced by 4-aminopyridine].
    Molgo J; Lemeignan M; Lechat P
    C R Acad Hebd Seances Acad Sci D; 1975 Nov; 281(21):1637-9. PubMed ID: 3292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prejunctional inhibitory effect of suramin on neuromuscular transmission in vitro.
    Henning RH; Rowan EG; Braga MF; Nelemans A; Harvey AL
    Eur J Pharmacol; 1996 Apr; 301(1-3):91-7. PubMed ID: 8773451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic and postsynaptic effects of the venom of the Australian tiger snake at the neuromuscular junction.
    Datyner ME; Gage PW
    Br J Pharmacol; 1973 Oct; 49(2):340-54. PubMed ID: 4367126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation between quantum content and facilitation at the neuromuscular junction of the frog.
    Mallart A; Martin AR
    J Physiol; 1968 Jun; 196(3):593-604. PubMed ID: 4298821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An attempt to distinguish between the actions of neuromuscular blocking drugs on the acetylcholine receptor and on its associated ionic channel.
    Lambert JJ; Volle RL; Henderson EG
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):5003-7. PubMed ID: 6254051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of an inhibitor of the synaptic vesicle acetylcholine transport system on quantal neurotransmitter release: an electrophysiological study.
    Lupa MT
    Brain Res; 1988 Sep; 461(1):118-26. PubMed ID: 3265645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of cholinergic agents on the release of transmitter at the frog neuromuscular junction.
    Duncan CJ; Publicover SJ
    J Physiol; 1979 Sep; 294():91-103. PubMed ID: 229216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual effect of calmidazolium (R 24571) on transmitter release at the frog neuromuscular junction.
    Sahaf ZY; Publicover SJ
    Brain Res; 1985 Nov; 348(1):192-6. PubMed ID: 2998560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic effects of d-tubocurarine on neurotransmitter release at the neuromuscular junction of the frog.
    Matzner H; Parnas H; Parnas I
    J Physiol; 1988 Apr; 398():109-21. PubMed ID: 2899171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical parameters of transmitter release at frog neuromuscular junctions treated with guanidine or tetraethylammonium.
    Volle RL; Branisteanu DD
    J Pharmacol Exp Ther; 1976 Jun; 197(3):653-61. PubMed ID: 6788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine: myoneural activity and interaction with neuromuscular blocking agents.
    Cronnelly R; Dretchen KL; Sokoll MD; Long JP
    Eur J Pharmacol; 1973 Apr; 22(1):17-22. PubMed ID: 4267587
    [No Abstract]   [Full Text] [Related]  

  • 18. [Variations in the sensitivity of the neuromuscular junctions of the frog to the blocking action of hyperkalemic solutions].
    Dobretsov MG
    Fiziol Zh SSSR Im I M Sechenova; 1987 Mar; 73(3):366-72. PubMed ID: 3034684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative patterns of tubocurarine action on the synaptic potentials of frog muscle].
    Grigor'ev VM; Danilov AF; Skliarov AI
    Fiziol Zh SSSR Im I M Sechenova; 1988 Sep; 74(9):1228-34. PubMed ID: 2850942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of neuromuscular blocks by germine monoacetate.
    Higashi H; Yonemura K; Shimoji K
    Anesthesiology; 1973 Feb; 38(2):145-52. PubMed ID: 4265216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.